Data / Form D filings / Qnovia, Inc.
Qnovia, Inc.: Form D filings
Qnovia, Inc., a pharmaceuticals company in Richmond, VA, filed 3 Form D notices with the SEC between 2022 and 2024. The latest, on November 12, 2024, reports $14.2 million sold of a $16 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2920 WEST BROAD ST., SUITE 243, Richmond, VA, 23230
- Phone
- (973) 865-9982
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1940918
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 12, 2024 | New notice | $16,000,000 | $14,210,860 | $1,789,140 | 7 | Oct 29, 2024 | sec.gov |
| Jun 7, 2023 | New notice | $5,000,013 | $2,874,968 | $2,125,045 | 3 | May 25, 2023 | sec.gov |
| Aug 8, 2022 | New notice | $30,000,000 | $24,182,042 | $5,817,958 | 0 | Jun 28, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mario Danek | Executive Officer, Director | |
| Sean Fahey | Director | |
| Brian Quigley | Executive Officer, Director | |
| Brian Riano | Director | |
| Gregg Smith | Director |
Other pharmaceuticals companies in Virginia that filed recently
- Quoin Pharmaceuticals Ltd. $50 million · Sep 10, 2026
Every Form D from the week of Nov 11, 2024 · All recent filings in Virginia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Qnovia, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.